Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients

BACKGROUND AND PURPOSE: In patients with acute ischemic stroke (AIS) using a direct oral factor-Xa anticoagulant (DOAC) during the last 48 hours, a fixed plasma heparin-calibrated anti-Xa activity (0.5 IU/mL) was proposed as a threshold below which patients could be eligible for thrombolysis and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Brakta, Charlyne, Stépanian, Alain, Reiner, Peggy, Delrue, Maxime, Mazighi, Mikaël, Curis, Emmanuel, Siguret, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911839/
https://www.ncbi.nlm.nih.gov/pubmed/36592965
http://dx.doi.org/10.5853/jos.2022.03034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911839/
https://www.ncbi.nlm.nih.gov/pubmed/36592965
http://dx.doi.org/10.5853/jos.2022.03034

Ejemplares similares